155 related articles for article (PubMed ID: 26196875)
1. Nephrotoxicity by Administration of Hyperchloremic Solutions.
Priebe HJ
Anesthesiology; 2015 Aug; 123(2):481. PubMed ID: 26196875
[No Abstract] [Full Text] [Related]
2. Lack of Nephrotoxicity of Hydroxyethyl Starch 130/0.4 When Used in Surgery.
Weiskopf RB
Anesthesiology; 2015 Aug; 123(2):482-3. PubMed ID: 26196877
[No Abstract] [Full Text] [Related]
3. Is Hydroxyethyl Starch 130/0.4 Safe for the Kidney in Noncardiac Surgical Patients?
Xue FS; Cui XL; Wang SY
Anesthesiology; 2015 Aug; 123(2):481-2. PubMed ID: 26196876
[No Abstract] [Full Text] [Related]
4. In Reply.
Pinholt Kancir AS; Ekeløf NP; Pedersen EB
Anesthesiology; 2015 Aug; 123(2):483-4. PubMed ID: 26196878
[No Abstract] [Full Text] [Related]
5. Lack of nephrotoxicity by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a randomized controlled trial.
Kancir AS; Pleckaitiene L; Hansen TB; Ekeløf NP; Pedersen EB
Anesthesiology; 2014 Nov; 121(5):948-58. PubMed ID: 25127210
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch 130/0.4: safe for the kidney in surgical patients?
Wiedermann CJ
Anesthesiology; 2013 Sep; 119(3):735-6. PubMed ID: 23962943
[No Abstract] [Full Text] [Related]
7. Hydroxyethyl starch 130/0.4 and postoperative acute kidney injury.
Groeneveld AB; Navickis RJ; Wilkes MM
Anesthesiology; 2013 Sep; 119(3):733-5. PubMed ID: 23962942
[No Abstract] [Full Text] [Related]
8. Colloid solutions in the perioperative setting.
Haase N; Perner A
BMJ; 2015 Mar; 350():h1656. PubMed ID: 25817457
[No Abstract] [Full Text] [Related]
9. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.
Wiedermann CJ
Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021
[No Abstract] [Full Text] [Related]
10. In reply.
Martin C; Jacob M; Vicaut E; Guidet B; Van Aken H; Kurz A
Anesthesiology; 2013 Sep; 119(3):736-7. PubMed ID: 23962944
[No Abstract] [Full Text] [Related]
11. Renal dysfunction after hydroxyethyl starch.
Celik I
Anesth Analg; 2004 Jul; 99(1):309-310. PubMed ID: 15281561
[No Abstract] [Full Text] [Related]
12. An international review of HES.
Riou B; Cittanova ML
Intensive Care Med; 1999 Nov; 25(11):1340-1. PubMed ID: 10654230
[No Abstract] [Full Text] [Related]
13. [Controversy over the use of hydroxyethyl starch solutions. Is the use of low molecular weight hydroxyethyl starch contraindicated?].
Sánchez CA; Asuero MS;
Rev Esp Anestesiol Reanim; 2014; 61(6):299-303. PubMed ID: 24838121
[No Abstract] [Full Text] [Related]
14. The nephrotoxicity of 6% Hydroxyethyl Starch 130/0.4 in surgery.
Kancir AS
Acta Anaesthesiol Scand; 2016 Apr; 60(4):548-9. PubMed ID: 26941118
[No Abstract] [Full Text] [Related]
15. Stable creatinine clearance using large-dose HES versus reduced GFR.
Neff TA; Stocker R
Kidney Int; 2004 Mar; 65(3):1111; author reply 1111-2. PubMed ID: 14871435
[No Abstract] [Full Text] [Related]
16. Nephrotoxicity of hydroxyethyl starch solution.
Brunkhorst FM; Oppert M
Br J Anaesth; 2008 Jun; 100(6):856; author reply 856-7. PubMed ID: 18483113
[No Abstract] [Full Text] [Related]
17. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
Mills GH
Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208
[No Abstract] [Full Text] [Related]
18. Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions.
Bayer O; Reinhart K
Crit Care; 2015 May; 19(1):209. PubMed ID: 25940561
[No Abstract] [Full Text] [Related]
19. Hydroxyethyl starch solutions and patient harm.
Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K
Lancet; 2018 Feb; 391(10122):736. PubMed ID: 29449012
[No Abstract] [Full Text] [Related]
20. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
Ittner KP
Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
